Axsome Therapeutics, Inc. AXSM
137.00 USD -2.61 (-1.87%)
At closeNov 4, 2026, 4:00 PM EST
137.00 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
134.38 Day range 140.56
123.00 52-week range 260.19
- YTD
- -24.99%
- 1 year
- +1.53%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 271.05 +97.8% upside
Now 137.00
- Target (low)
- 220.00
- Target (mean)
- 271.05
- Target (high)
- 380.00
Ratings (0m) 22 21 buy · 1 hold · 0 sell
- Strong buy3
- Buy18
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 22
- 1 month ago 22
- 2 months ago 21
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.07737 | -1.00 – -0.41 | -0.56 | +86.2% | 285.67M | +45.8% | 13 |
| Next quarter | 0.03 | -0.21 – 0.36 | -0.56 | +105.4% | 295.92M | +54.8% | 10 |
| Current year | -2.60 | -3.03 – -2.05 | -3.47 | +25.1% | 953.96M | +49.4% | 9 |
| Next year | 4.02 | 1.30 – 7.84 | -2.60 | +254.6% | 1.46B | +52.5% | 12 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 4, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Nov 3, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 3, 2026 | UBS | Maintained | Buy | Buy |
| Nov 3, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 3, 2026 | Guggenheim | Maintained | Buy | Buy |
| Nov 3, 2026 | Baird | Maintained | Outperform | Outperform |
| Oct 26, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 29, 2026 | Deutsche Bank | Maintained | Buy | Buy |
| Sep 25, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Sep 23, 2026 | Truist Securities | Maintained | Buy | Buy |
| Sep 18, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Aug 31, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 12, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Aug 11, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 11, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 11, 2026 | Guggenheim | Maintained | Buy | Buy |
| Aug 11, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 11, 2026 | Needham | Maintained | Buy | Buy |
| Jul 31, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 21, 2026 | BMO Capital | Initiated | — | Outperform |
| Jul 15, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 8, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 17, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 5, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 5, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 5, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 5, 2026 | Guggenheim | Maintained | Buy | Buy |
| May 5, 2026 | Mizuho | Maintained | Outperform | Outperform |